Trifluoroacetic acid → HCID 46893526, compound
Reaction equation
[Cl:1][C:2]1[CH:3]=[C:4]([C:42]([F:45])([F:44])[F:43])[CH:5]=[C:6]2[C:10]=1[N:9]([CH3:11])[N:8]=[C:7]2[CH:12]([C:35]1[CH:40]=[CH:39][C:38]([Cl:41])=[CH:37][CH:36]=1)[CH:13]([C:17]1[CH:34]=[CH:33][C:20]([C:21]([NH:23][CH2:24][CH2:25][C:26]([O:28]C(C)(C)C)=[O:27])=[O:22])=[CH:19][CH:18]=1)[CH2:14][CH2:15][CH3:16].C(O)(C(F)(F)F)=O>C(Cl)Cl>[Cl:1][C:2]1[CH:3]=[C:4]([C:42]([F:44])([F:43])[F:45])[CH:5]=[C:6]2[C:10]=1[N:9]([CH3:11])[N:8]=[C:7]2[CH:12]([C:35]1[CH:40]=[CH:39][C:38]([Cl:41])=[CH:37][CH:36]=1)[CH:13]([C:17]1[CH:34]=[CH:33][C:20]([C:21]([NH:23][CH2:24][CH2:25][C:26]([OH:28])=[O:27])=[O:22])=[CH:19][CH:18]=1)[CH2:14][CH2:15][CH3:16]Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of the slower-eluting enantiomer of the product from Step B (4.6 mg, 0.0069 mmol) in DCM (1 mL) was added TFA (1 mL, 13 mmol), and the solution was stirred for 30 minutes at RT. The solution was concentrated, then the residue was purified by reverse phase HPLC eluting with acetonitrile/water+0.1% TFA. Following lyophilization, this afforded the enantiopure title compound as a white solid. 1H NMR (500 MHz, CD3OD): δ 7.92 (s, 1H); 7.62 (d, J=8.5 Hz, 2H); 7.53 (d, J=8.3 Hz, 2H); 7.43 (s, 1H); 7.36 (d, J=8.2 Hz, 2H); 7.33 (d, J=8.5 Hz, 2H); 4.78 (d, 3=11.5 Hz, 1H); 4.26 (s, 3H); 3.72 (td, J=11.4, 3.2 Hz, 1H); 3.52 (t, J=6.9 Hz, 2H); 2.55 (t, J=6.9 Hz, 2H); 1.68-1.57 (m, 1H); 1.50-1.43 (m, 1H); 1.05-0.97 (m, 2H); 0.73 (t, J=7.3 Hz, 3H); LC2 1.31 min. (M+H)+ 606.
Workup
- concentrationThe solution was concentrated
- customthe residue was purified by reverse phase HPLC
- washeluting with acetonitrile/water+0.1% TFA
Sources & evidence
- ORD record
- ord-4fe7a17432f24f7bb05b040ccd4aebf8
- Source dataset
- uspto-grants-2012_11
- Patent number
- US08318667B2
Reaction notes
Loading…